By contrast, in our study, though we also studied the levels of transferrin we did not find significant differences between patients with CRC and controls, (225.4±53.69 vs 231.1±37.1; p = 0.60) with an area under the ROC curve of 0.47 (0.34 to 0.61). The gene discussed is TF; the disease is colorectal carcinoma.